{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:40Z","timestamp":1786136020647,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170949"],"award-info":[{"award-number":["32170949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0490300"],"award-info":[{"award-number":["XDB0490300"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.virs.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:07:55Z","timestamp":1779980875000},"page":"688-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration"],"prefix":"10.1016","volume":"41","author":[{"given":"Bihao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-5642","authenticated-orcid":false,"given":"Rui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.05.007_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.05.007_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.antiviral.2014.06.007","article-title":"Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs","volume":"109","author":"An","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.05.007_bib3","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of Influenza Oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.05.007_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-biophys-070317-033018","article-title":"Hemagglutinin-mediated membrane fusion: a biophysical perspective","volume":"47","author":"Boonstra","year":"2018","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.virs.2026.05.007_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1689027","article-title":"An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding","volume":"12","author":"Cao","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.virs.2026.05.007_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and Group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.05.007_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S2213-2600(20)30320-9","article-title":"Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Cunningham","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.virs.2026.05.007_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.05.007_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.05.007_bib10","series-title":"Therapeutic Proteins: Methods and Protocols","first-page":"85","article-title":"Expression, purification, and characterization of engineered antibody CH2 and VH domains","author":"Gong","year":"2012"},{"key":"10.1016\/j.virs.2026.05.007_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042288","article-title":"Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn","volume":"7","author":"Gong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.05.007_bib12","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1021\/mp400075f","article-title":"N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance","volume":"10","author":"Gong","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.virs.2026.05.007_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","article-title":"Broadly neutralizing antibodies target a haemagglutinin anchor epitope","volume":"602","author":"Guthmiller","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.05.007_bib14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virs.2026.05.007_bib15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2026.05.007_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.05.007_bib17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.05.007_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.05.007_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.05.007_bib20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.05.007_bib21","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1074\/jbc.M109.067090","article-title":"Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain","volume":"285","author":"Kondo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virs.2026.05.007_bib22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virs.2026.05.007_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/19420862.2018.1470727","article-title":"Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs","volume":"10","author":"Larios Mora","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.virs.2026.05.007_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1126\/science.aaq0620","article-title":"Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin","volume":"362","author":"Laursen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.05.007_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acs.molpharmaceut.4c00980","article-title":"Comparison of C-type nanoantibody produced in different expression systems implying potential clinical applications","volume":"22","author":"Li","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.virs.2026.05.007_bib26","doi-asserted-by":"crossref","first-page":"ofab630","DOI":"10.1093\/ofid\/ofab630","article-title":"A phase 2 randomized, double-blind, placebo-controlled trial of the monoclonal antibody MHAA4549A in patients with acute uncomplicated influenza A infection","volume":"9","author":"Lim","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.virs.2026.05.007_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virs.2026.05.007_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh0319","article-title":"Inhalable nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses","volume":"7","author":"Nambulli","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virs.2026.05.007_bib29","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.05.007_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.05.007_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.virs.2026.05.007_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.05.007_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.virs.2026.05.007_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104763","article-title":"Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study","volume":"184","author":"Sloan","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.05.007_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10529-007-9521-4","article-title":"A dual reporter gene based system to quantitate the cell fusion of avian influenza virus H5N1","volume":"30","author":"Su","year":"2008","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.virs.2026.05.007_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105785","article-title":"Broadly neutralizing antibodies to combat influenza virus infection","volume":"221","author":"Sun","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.05.007_bib37","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s12250-021-00454-z","article-title":"Identification and characterization of a novel single domain antibody against ebola virus","volume":"36","author":"Wang","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2026.05.007_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virs.2026.05.007_bib39","first-page":"217","volume":"vol. 8","author":"Wooliscroft","year":"2008"},{"key":"10.1016\/j.virs.2026.05.007_bib40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Xiang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.05.007_bib41","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.3390\/ijms22073384","article-title":"Airway surface liquid pH regulation in airway epithelium current understandings and gaps in knowledge","volume":"22","author":"Zajac","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virs.2026.05.007_bib42","article-title":"A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.05.007_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jmb.2003.09.055","article-title":"Improved breadth and potency of an HIV-1-Neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning","volume":"335","author":"Zhang","year":"2004","journal-title":"J. Mol. Biol."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:03:32Z","timestamp":1786133012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1995820X26000854"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.05.007","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}